128 related articles for article (PubMed ID: 36939506)
1. A case of eczematous eruption occurring during treatment with risankizumab.
DE Luca E; Caldarola G; DI Stefani A; D'Amore A; Sfregola S; DE Simone C
Ital J Dermatol Venerol; 2023 Feb; 158(1):64-65. PubMed ID: 36939506
[No Abstract] [Full Text] [Related]
2. Eczematous eruption in patients with psoriasis during risankizumab treatment.
Kromer C; Schön MP; Mössner R
Eur J Dermatol; 2020 Oct; 30(5):599-601. PubMed ID: 33185530
[No Abstract] [Full Text] [Related]
3. A Case Series of Patients With Eczematous Eruptions Following IL-17 Inhibitor Treatment for Psoriasis Vulgaris.
Yousif J; Al-Dehneem R; Kaskas N; Gottlieb AB
J Drugs Dermatol; 2023 Dec; 22(12):1225-1227. PubMed ID: 38051861
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab for severe generalized eczematous eruption complicating common variable immunodeficiency.
Votquenne N; Dupire G; Michel O; Ben Said B
Eur J Dermatol; 2021 Feb; 31(1):93-94. PubMed ID: 33586652
[No Abstract] [Full Text] [Related]
5. Treatment of paradoxical eczematous eruption in psoriasis treated with secukinumab: A case report.
Xiao Y; Peng S; Li X; Mao T; Fang M; Hu Y; Ye W
Medicine (Baltimore); 2023 Feb; 102(6):e32844. PubMed ID: 36820537
[TBL] [Abstract][Full Text] [Related]
6. Brodalumab-Induced Eczematous Reactions in Psoriasis Patients: Management With Switching to Risankizumab.
Alsenaid A; Piguet V; Lansang P; Miller-Monthrope Y; Yeung J; Joseph M
J Cutan Med Surg; 2023; 27(3):236-240. PubMed ID: 37014149
[TBL] [Abstract][Full Text] [Related]
7. Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.
Takci Z; Guler Simsek G; Uzuner H; Akbayrak A; Yıldız Seckin H; Karadag AS
Dermatol Ther; 2020 Nov; 33(6):e14147. PubMed ID: 32767429
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin-induced severe vesicular eczematous eruption successfully treated with narrow band-ultraviolet B therapy.
Koizumi R; Fukumoto T; Jimbo H; Nishigori C
Photodermatol Photoimmunol Photomed; 2021 Sep; 37(5):371-373. PubMed ID: 33559335
[TBL] [Abstract][Full Text] [Related]
9. Eczematous drug eruption after ustekinumab treatment.
Pernet C; Guillot B; Bessis D
Arch Dermatol; 2012 Aug; 148(8):959-60. PubMed ID: 22911203
[No Abstract] [Full Text] [Related]
10. Eczematous drug eruption after infliximab.
Dumont-Berset M; Laffitte E; Gerber C; Dudler J; Panizzon RG
Br J Dermatol; 2004 Dec; 151(6):1272-3. PubMed ID: 15606528
[No Abstract] [Full Text] [Related]
11. Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study.
Cohen Aubart F; Barete S; Amoura Z; Francès C; Lyon-Caen O; Lebrun-Vignes B
Eur J Intern Med; 2009 Jan; 20(1):70-3. PubMed ID: 19237096
[TBL] [Abstract][Full Text] [Related]
12. The role of dupilumab in the management of idiopathic chronic eczematous eruption of aging.
Shahriari N; Strober B; Shahriari M
J Am Acad Dermatol; 2020 Nov; 83(5):1533-1535. PubMed ID: 32679275
[No Abstract] [Full Text] [Related]
13. A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging.
Brummer GC; Wang LT; Sontheimer RD
Dermatol Online J; 2018 Feb; 24(2):. PubMed ID: 29630150
[TBL] [Abstract][Full Text] [Related]
14. Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab.
Megna M; Genco L; Noto M; Patruno C; Fabbrocini G; Napolitano M
Dermatol Ther; 2022 Nov; 35(11):e15839. PubMed ID: 36111349
[No Abstract] [Full Text] [Related]
15. Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA).
Shahin TB; Sreekantaswamy SA; Hawkes JE; Butler DC
Am J Clin Dermatol; 2023 May; 24(3):405-418. PubMed ID: 36920748
[TBL] [Abstract][Full Text] [Related]
16. Brodalumab-associated generalized eczematous eruption in a difficult-to-treat psoriasis patient: management without brodalumab withdrawal.
Danset M; Hacard F; Jaulent C; Nosbaum A; Berard F; Nicolas JF; Goujon C
Eur J Dermatol; 2020 Dec; 30(6):741-743. PubMed ID: 33337328
[No Abstract] [Full Text] [Related]
17. Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition.
Napolitano M; Megna M; Fabbrocini G; Nisticò SP; Balato N; Dastoli S; Patruno C
Br J Dermatol; 2019 Sep; 181(3):604-606. PubMed ID: 30768788
[No Abstract] [Full Text] [Related]
18. Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab.
Bard S; Paravisini A; Avilés-Izquierdo JA; Fernandez-Cruz E; Sánchez-Ramón S
Arch Dermatol; 2008 Dec; 144(12):1662-3. PubMed ID: 19075161
[No Abstract] [Full Text] [Related]
19. [Kaposi's varicelliforme eruption, eczema herpetiforme].
LAUSECKER H
Arch Dermatol Syph; 1953; 196(2):183-222. PubMed ID: 13125396
[No Abstract] [Full Text] [Related]
20. [RECENT ADVANCES IN THE TREATMENT OF ACUTE AND CHRONIC ECZEMATOUS SKIN ERUPTIONS].
YASUDA T
Jibiinkoka; 1964 Dec; 36():1167-72. PubMed ID: 14278382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
